nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Budesonide—ulcerative colitis	0.107	0.183	CbGbCtD
Darifenacin—CYP2D6—Nicotine—ulcerative colitis	0.0732	0.125	CbGbCtD
Darifenacin—CYP2D6—Cholecalciferol—ulcerative colitis	0.0656	0.112	CbGbCtD
Darifenacin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0478	0.0818	CbGbCtD
Darifenacin—CYP3A4—Nicotine—ulcerative colitis	0.0465	0.0797	CbGbCtD
Darifenacin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0417	0.0715	CbGbCtD
Darifenacin—CYP3A4—Triamcinolone—ulcerative colitis	0.0362	0.062	CbGbCtD
Darifenacin—CYP3A4—Betamethasone—ulcerative colitis	0.0311	0.0532	CbGbCtD
Darifenacin—CYP3A4—Prednisolone—ulcerative colitis	0.0306	0.0525	CbGbCtD
Darifenacin—CYP3A4—Hydrocortisone—ulcerative colitis	0.029	0.0497	CbGbCtD
Darifenacin—CYP3A4—Prednisone—ulcerative colitis	0.0289	0.0495	CbGbCtD
Darifenacin—CYP2D6—Dexamethasone—ulcerative colitis	0.0284	0.0486	CbGbCtD
Darifenacin—CYP3A4—Dexamethasone—ulcerative colitis	0.0181	0.0309	CbGbCtD
Darifenacin—Loperamide—CALM3—ulcerative colitis	0.00405	0.618	CrCbGaD
Darifenacin—Fexofenadine—ABCB1—ulcerative colitis	0.00071	0.108	CrCbGaD
Darifenacin—Dyspepsia—Mesalazine—ulcerative colitis	0.000589	0.00163	CcSEcCtD
Darifenacin—Eye disorder—Methylprednisolone—ulcerative colitis	0.000588	0.00163	CcSEcCtD
Darifenacin—Mental disorder—Hydrocortisone—ulcerative colitis	0.000587	0.00162	CcSEcCtD
Darifenacin—Pruritus—Budesonide—ulcerative colitis	0.000582	0.00161	CcSEcCtD
Darifenacin—Abdominal pain—Azathioprine—ulcerative colitis	0.000581	0.00161	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000578	0.0016	CcSEcCtD
Darifenacin—Erectile dysfunction—Prednisone—ulcerative colitis	0.000573	0.00158	CcSEcCtD
Darifenacin—Pain—Mesalazine—ulcerative colitis	0.000572	0.00158	CcSEcCtD
Darifenacin—Constipation—Mesalazine—ulcerative colitis	0.000572	0.00158	CcSEcCtD
Darifenacin—Angiopathy—Methylprednisolone—ulcerative colitis	0.000571	0.00158	CcSEcCtD
Darifenacin—Hallucination—Betamethasone—ulcerative colitis	0.000569	0.00157	CcSEcCtD
Darifenacin—Hallucination—Dexamethasone—ulcerative colitis	0.000569	0.00157	CcSEcCtD
Darifenacin—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000567	0.00157	CcSEcCtD
Darifenacin—Weight increased—Prednisone—ulcerative colitis	0.000567	0.00157	CcSEcCtD
Darifenacin—Diarrhoea—Budesonide—ulcerative colitis	0.000563	0.00156	CcSEcCtD
Darifenacin—Vision blurred—Prednisolone—ulcerative colitis	0.000563	0.00156	CcSEcCtD
Darifenacin—Visual impairment—Betamethasone—ulcerative colitis	0.000551	0.00152	CcSEcCtD
Darifenacin—Visual impairment—Dexamethasone—ulcerative colitis	0.000551	0.00152	CcSEcCtD
Darifenacin—Feeling abnormal—Mesalazine—ulcerative colitis	0.000551	0.00152	CcSEcCtD
Darifenacin—Mental disorder—Methylprednisolone—ulcerative colitis	0.000551	0.00152	CcSEcCtD
Darifenacin—Clotrimazole—ABCB1—ulcerative colitis	0.000549	0.0838	CrCbGaD
Darifenacin—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000547	0.00151	CcSEcCtD
Darifenacin—Angioedema—Prednisolone—ulcerative colitis	0.000545	0.00151	CcSEcCtD
Darifenacin—Dizziness—Budesonide—ulcerative colitis	0.000544	0.0015	CcSEcCtD
Darifenacin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000541	0.0015	CcSEcCtD
Darifenacin—Dysgeusia—Triamcinolone—ulcerative colitis	0.000538	0.00149	CcSEcCtD
Darifenacin—Syncope—Prednisolone—ulcerative colitis	0.000535	0.00148	CcSEcCtD
Darifenacin—Eye disorder—Betamethasone—ulcerative colitis	0.000535	0.00148	CcSEcCtD
Darifenacin—Eye disorder—Dexamethasone—ulcerative colitis	0.000535	0.00148	CcSEcCtD
Darifenacin—Angioedema—Hydrocortisone—ulcerative colitis	0.000533	0.00147	CcSEcCtD
Darifenacin—Back pain—Triamcinolone—ulcerative colitis	0.000531	0.00147	CcSEcCtD
Darifenacin—Abdominal pain—Mesalazine—ulcerative colitis	0.000529	0.00146	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisolone—ulcerative colitis	0.000525	0.00145	CcSEcCtD
Darifenacin—Vomiting—Budesonide—ulcerative colitis	0.000523	0.00145	CcSEcCtD
Darifenacin—Syncope—Hydrocortisone—ulcerative colitis	0.000523	0.00145	CcSEcCtD
Darifenacin—Angiopathy—Dexamethasone—ulcerative colitis	0.000519	0.00143	CcSEcCtD
Darifenacin—Angiopathy—Betamethasone—ulcerative colitis	0.000519	0.00143	CcSEcCtD
Darifenacin—Rash—Budesonide—ulcerative colitis	0.000519	0.00143	CcSEcCtD
Darifenacin—Dermatitis—Budesonide—ulcerative colitis	0.000518	0.00143	CcSEcCtD
Darifenacin—Headache—Budesonide—ulcerative colitis	0.000515	0.00142	CcSEcCtD
Darifenacin—Hypertension—Prednisolone—ulcerative colitis	0.000515	0.00142	CcSEcCtD
Darifenacin—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000512	0.00142	CcSEcCtD
Darifenacin—Hypertension—Hydrocortisone—ulcerative colitis	0.000503	0.00139	CcSEcCtD
Darifenacin—Diarrhoea—Azathioprine—ulcerative colitis	0.000503	0.00139	CcSEcCtD
Darifenacin—Angioedema—Triamcinolone—ulcerative colitis	0.000502	0.00139	CcSEcCtD
Darifenacin—Angioedema—Methylprednisolone—ulcerative colitis	0.000501	0.00138	CcSEcCtD
Darifenacin—Hallucination—Prednisone—ulcerative colitis	0.000496	0.00137	CcSEcCtD
Darifenacin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000493	0.00136	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000493	0.00136	CcSEcCtD
Darifenacin—Syncope—Triamcinolone—ulcerative colitis	0.000492	0.00136	CcSEcCtD
Darifenacin—Syncope—Methylprednisolone—ulcerative colitis	0.000491	0.00136	CcSEcCtD
Darifenacin—Nausea—Budesonide—ulcerative colitis	0.000489	0.00135	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000487	0.00135	CcSEcCtD
Darifenacin—Oedema—Prednisolone—ulcerative colitis	0.000487	0.00135	CcSEcCtD
Darifenacin—Dizziness—Azathioprine—ulcerative colitis	0.000486	0.00134	CcSEcCtD
Darifenacin—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000483	0.00133	CcSEcCtD
Darifenacin—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000481	0.00133	CcSEcCtD
Darifenacin—Asthenia—Mesalazine—ulcerative colitis	0.00048	0.00133	CcSEcCtD
Darifenacin—Shock—Prednisolone—ulcerative colitis	0.000479	0.00132	CcSEcCtD
Darifenacin—Cough—Triamcinolone—ulcerative colitis	0.000479	0.00132	CcSEcCtD
Darifenacin—Oedema—Hydrocortisone—ulcerative colitis	0.000476	0.00132	CcSEcCtD
Darifenacin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000476	0.00132	CcSEcCtD
Darifenacin—Tachycardia—Prednisolone—ulcerative colitis	0.000476	0.00131	CcSEcCtD
Darifenacin—Hypertension—Triamcinolone—ulcerative colitis	0.000474	0.00131	CcSEcCtD
Darifenacin—Pruritus—Mesalazine—ulcerative colitis	0.000473	0.00131	CcSEcCtD
Darifenacin—Hypertension—Methylprednisolone—ulcerative colitis	0.000473	0.00131	CcSEcCtD
Darifenacin—Infection—Hydrocortisone—ulcerative colitis	0.000473	0.00131	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000471	0.0013	CcSEcCtD
Darifenacin—Fentanyl—ABCB1—ulcerative colitis	0.000469	0.0716	CrCbGaD
Darifenacin—Shock—Hydrocortisone—ulcerative colitis	0.000468	0.00129	CcSEcCtD
Darifenacin—Vomiting—Azathioprine—ulcerative colitis	0.000467	0.00129	CcSEcCtD
Darifenacin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000467	0.00129	CcSEcCtD
Darifenacin—Arthralgia—Methylprednisolone—ulcerative colitis	0.000466	0.00129	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—ulcerative colitis	0.000466	0.00129	CcSEcCtD
Darifenacin—Tachycardia—Hydrocortisone—ulcerative colitis	0.000464	0.00128	CcSEcCtD
Darifenacin—Rash—Azathioprine—ulcerative colitis	0.000463	0.00128	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000463	0.00128	CcSEcCtD
Darifenacin—Dermatitis—Azathioprine—ulcerative colitis	0.000463	0.00128	CcSEcCtD
Darifenacin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000462	0.00128	CcSEcCtD
Darifenacin—Headache—Azathioprine—ulcerative colitis	0.00046	0.00127	CcSEcCtD
Darifenacin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00046	0.00127	CcSEcCtD
Darifenacin—Diarrhoea—Mesalazine—ulcerative colitis	0.000458	0.00127	CcSEcCtD
Darifenacin—Dry mouth—Triamcinolone—ulcerative colitis	0.000457	0.00126	CcSEcCtD
Darifenacin—Angioedema—Dexamethasone—ulcerative colitis	0.000455	0.00126	CcSEcCtD
Darifenacin—Angioedema—Betamethasone—ulcerative colitis	0.000455	0.00126	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—ulcerative colitis	0.000452	0.00125	CcSEcCtD
Darifenacin—Loperamide—ABCB1—ulcerative colitis	0.000452	0.069	CrCbGaD
Darifenacin—Confusional state—Methylprednisolone—ulcerative colitis	0.000451	0.00125	CcSEcCtD
Darifenacin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000448	0.00124	CcSEcCtD
Darifenacin—Oedema—Triamcinolone—ulcerative colitis	0.000448	0.00124	CcSEcCtD
Darifenacin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000447	0.00124	CcSEcCtD
Darifenacin—Syncope—Betamethasone—ulcerative colitis	0.000447	0.00123	CcSEcCtD
Darifenacin—Syncope—Dexamethasone—ulcerative colitis	0.000447	0.00123	CcSEcCtD
Darifenacin—Infection—Triamcinolone—ulcerative colitis	0.000445	0.00123	CcSEcCtD
Darifenacin—Infection—Methylprednisolone—ulcerative colitis	0.000444	0.00123	CcSEcCtD
Darifenacin—Dizziness—Mesalazine—ulcerative colitis	0.000443	0.00122	CcSEcCtD
Darifenacin—Shock—Triamcinolone—ulcerative colitis	0.000441	0.00122	CcSEcCtD
Darifenacin—Insomnia—Prednisolone—ulcerative colitis	0.000441	0.00122	CcSEcCtD
Darifenacin—Shock—Methylprednisolone—ulcerative colitis	0.00044	0.00122	CcSEcCtD
Darifenacin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000438	0.00121	CcSEcCtD
Darifenacin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000438	0.00121	CcSEcCtD
Darifenacin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000438	0.00121	CcSEcCtD
Darifenacin—Tachycardia—Triamcinolone—ulcerative colitis	0.000437	0.00121	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—ulcerative colitis	0.000437	0.00121	CcSEcCtD
Darifenacin—Nausea—Azathioprine—ulcerative colitis	0.000436	0.00121	CcSEcCtD
Darifenacin—Tachycardia—Methylprednisolone—ulcerative colitis	0.000436	0.00121	CcSEcCtD
Darifenacin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000434	0.0012	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000434	0.0012	CcSEcCtD
Darifenacin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000433	0.0012	CcSEcCtD
Darifenacin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000432	0.00119	CcSEcCtD
Darifenacin—Insomnia—Hydrocortisone—ulcerative colitis	0.00043	0.00119	CcSEcCtD
Darifenacin—Hypertension—Betamethasone—ulcerative colitis	0.00043	0.00119	CcSEcCtD
Darifenacin—Hypertension—Dexamethasone—ulcerative colitis	0.00043	0.00119	CcSEcCtD
Darifenacin—Vomiting—Mesalazine—ulcerative colitis	0.000425	0.00118	CcSEcCtD
Darifenacin—Rash—Mesalazine—ulcerative colitis	0.000422	0.00117	CcSEcCtD
Darifenacin—Dermatitis—Mesalazine—ulcerative colitis	0.000422	0.00117	CcSEcCtD
Darifenacin—Headache—Mesalazine—ulcerative colitis	0.000419	0.00116	CcSEcCtD
Darifenacin—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000419	0.00116	CcSEcCtD
Darifenacin—Pain—Prednisolone—ulcerative colitis	0.000417	0.00115	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000411	0.00114	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—ulcerative colitis	0.000409	0.00113	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000408	0.00113	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000407	0.00113	CcSEcCtD
Darifenacin—Pain—Hydrocortisone—ulcerative colitis	0.000407	0.00112	CcSEcCtD
Darifenacin—Oedema—Dexamethasone—ulcerative colitis	0.000407	0.00112	CcSEcCtD
Darifenacin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000407	0.00112	CcSEcCtD
Darifenacin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000407	0.00112	CcSEcCtD
Darifenacin—Oedema—Betamethasone—ulcerative colitis	0.000407	0.00112	CcSEcCtD
Darifenacin—Insomnia—Triamcinolone—ulcerative colitis	0.000405	0.00112	CcSEcCtD
Darifenacin—Insomnia—Methylprednisolone—ulcerative colitis	0.000404	0.00112	CcSEcCtD
Darifenacin—Infection—Betamethasone—ulcerative colitis	0.000404	0.00112	CcSEcCtD
Darifenacin—Infection—Dexamethasone—ulcerative colitis	0.000404	0.00112	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000401	0.00111	CcSEcCtD
Darifenacin—Shock—Dexamethasone—ulcerative colitis	0.0004	0.00111	CcSEcCtD
Darifenacin—Shock—Betamethasone—ulcerative colitis	0.0004	0.00111	CcSEcCtD
Darifenacin—Dyspnoea—Triamcinolone—ulcerative colitis	0.000399	0.0011	CcSEcCtD
Darifenacin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000399	0.0011	CcSEcCtD
Darifenacin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000399	0.0011	CcSEcCtD
Darifenacin—Nausea—Mesalazine—ulcerative colitis	0.000397	0.0011	CcSEcCtD
Darifenacin—Tachycardia—Dexamethasone—ulcerative colitis	0.000397	0.0011	CcSEcCtD
Darifenacin—Tachycardia—Betamethasone—ulcerative colitis	0.000397	0.0011	CcSEcCtD
Darifenacin—Angioedema—Prednisone—ulcerative colitis	0.000396	0.0011	CcSEcCtD
Darifenacin—Dyspepsia—Triamcinolone—ulcerative colitis	0.000394	0.00109	CcSEcCtD
Darifenacin—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000394	0.00109	CcSEcCtD
Darifenacin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000393	0.00109	CcSEcCtD
Darifenacin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000393	0.00109	CcSEcCtD
Darifenacin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000392	0.00108	CcSEcCtD
Darifenacin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000389	0.00108	CcSEcCtD
Darifenacin—Syncope—Prednisone—ulcerative colitis	0.000389	0.00108	CcSEcCtD
Darifenacin—Pain—Triamcinolone—ulcerative colitis	0.000383	0.00106	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—ulcerative colitis	0.000381	0.00105	CcSEcCtD
Darifenacin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000376	0.00104	CcSEcCtD
Darifenacin—Hypertension—Prednisone—ulcerative colitis	0.000375	0.00104	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.00037	0.00102	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.00037	0.00102	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—ulcerative colitis	0.000369	0.00102	CcSEcCtD
Darifenacin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000369	0.00102	CcSEcCtD
Darifenacin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000368	0.00102	CcSEcCtD
Darifenacin—Insomnia—Dexamethasone—ulcerative colitis	0.000368	0.00102	CcSEcCtD
Darifenacin—Insomnia—Betamethasone—ulcerative colitis	0.000368	0.00102	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000367	0.00101	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000366	0.00101	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000359	0.000992	CcSEcCtD
Darifenacin—Dyspepsia—Betamethasone—ulcerative colitis	0.000358	0.000989	CcSEcCtD
Darifenacin—Dyspepsia—Dexamethasone—ulcerative colitis	0.000358	0.000989	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000354	0.000979	CcSEcCtD
Darifenacin—Oedema—Prednisone—ulcerative colitis	0.000354	0.000979	CcSEcCtD
Darifenacin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000353	0.000977	CcSEcCtD
Darifenacin—Infection—Prednisone—ulcerative colitis	0.000352	0.000972	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000351	0.00097	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000351	0.00097	CcSEcCtD
Darifenacin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000351	0.000969	CcSEcCtD
Darifenacin—Shock—Prednisone—ulcerative colitis	0.000348	0.000963	CcSEcCtD
Darifenacin—Pain—Betamethasone—ulcerative colitis	0.000348	0.000961	CcSEcCtD
Darifenacin—Pain—Dexamethasone—ulcerative colitis	0.000348	0.000961	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—ulcerative colitis	0.000347	0.00096	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—ulcerative colitis	0.000346	0.000955	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—ulcerative colitis	0.000344	0.00095	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000342	0.000946	CcSEcCtD
Darifenacin—Asthenia—Hydrocortisone—ulcerative colitis	0.000341	0.000944	CcSEcCtD
Darifenacin—Pruritus—Hydrocortisone—ulcerative colitis	0.000337	0.00093	CcSEcCtD
Darifenacin—Feeling abnormal—Betamethasone—ulcerative colitis	0.000335	0.000926	CcSEcCtD
Darifenacin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000335	0.000926	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000332	0.000919	CcSEcCtD
Darifenacin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000332	0.000919	CcSEcCtD
Darifenacin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.00033	0.000912	CcSEcCtD
Darifenacin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000329	0.00091	CcSEcCtD
Darifenacin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000326	0.0009	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000323	0.000892	CcSEcCtD
Darifenacin—Dizziness—Prednisolone—ulcerative colitis	0.000322	0.00089	CcSEcCtD
Darifenacin—Methadone—ABCB1—ulcerative colitis	0.000322	0.0491	CrCbGaD
Darifenacin—Asthenia—Triamcinolone—ulcerative colitis	0.000321	0.000889	CcSEcCtD
Darifenacin—Abdominal pain—Betamethasone—ulcerative colitis	0.000321	0.000888	CcSEcCtD
Darifenacin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000321	0.000888	CcSEcCtD
Darifenacin—Asthenia—Methylprednisolone—ulcerative colitis	0.000321	0.000887	CcSEcCtD
Darifenacin—Insomnia—Prednisone—ulcerative colitis	0.00032	0.000885	CcSEcCtD
Darifenacin—Pruritus—Triamcinolone—ulcerative colitis	0.000317	0.000876	CcSEcCtD
Darifenacin—Pruritus—Methylprednisolone—ulcerative colitis	0.000316	0.000874	CcSEcCtD
Darifenacin—Dizziness—Hydrocortisone—ulcerative colitis	0.000315	0.00087	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—ulcerative colitis	0.000312	0.000861	CcSEcCtD
Darifenacin—Rash—Prednisolone—ulcerative colitis	0.000307	0.000849	CcSEcCtD
Darifenacin—Dermatitis—Prednisolone—ulcerative colitis	0.000307	0.000848	CcSEcCtD
Darifenacin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000306	0.000845	CcSEcCtD
Darifenacin—Headache—Prednisolone—ulcerative colitis	0.000305	0.000844	CcSEcCtD
Darifenacin—Constipation—Prednisone—ulcerative colitis	0.000303	0.000837	CcSEcCtD
Darifenacin—Vomiting—Hydrocortisone—ulcerative colitis	0.000303	0.000836	CcSEcCtD
Darifenacin—Rash—Hydrocortisone—ulcerative colitis	0.0003	0.000829	CcSEcCtD
Darifenacin—Dermatitis—Hydrocortisone—ulcerative colitis	0.0003	0.000828	CcSEcCtD
Darifenacin—Headache—Hydrocortisone—ulcerative colitis	0.000298	0.000824	CcSEcCtD
Darifenacin—Dizziness—Triamcinolone—ulcerative colitis	0.000296	0.000819	CcSEcCtD
Darifenacin—Dizziness—Methylprednisolone—ulcerative colitis	0.000296	0.000817	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—ulcerative colitis	0.000292	0.000806	CcSEcCtD
Darifenacin—Asthenia—Dexamethasone—ulcerative colitis	0.000292	0.000806	CcSEcCtD
Darifenacin—Asthenia—Betamethasone—ulcerative colitis	0.000292	0.000806	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00029	0.0008	CcSEcCtD
Darifenacin—Nausea—Prednisolone—ulcerative colitis	0.000289	0.0008	CcSEcCtD
Darifenacin—Pruritus—Dexamethasone—ulcerative colitis	0.000288	0.000795	CcSEcCtD
Darifenacin—Pruritus—Betamethasone—ulcerative colitis	0.000288	0.000795	CcSEcCtD
Darifenacin—Vomiting—Triamcinolone—ulcerative colitis	0.000285	0.000787	CcSEcCtD
Darifenacin—Vomiting—Methylprednisolone—ulcerative colitis	0.000284	0.000786	CcSEcCtD
Darifenacin—Nausea—Hydrocortisone—ulcerative colitis	0.000283	0.000781	CcSEcCtD
Darifenacin—Rash—Triamcinolone—ulcerative colitis	0.000283	0.000781	CcSEcCtD
Darifenacin—Dermatitis—Triamcinolone—ulcerative colitis	0.000282	0.00078	CcSEcCtD
Darifenacin—Rash—Methylprednisolone—ulcerative colitis	0.000282	0.000779	CcSEcCtD
Darifenacin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000282	0.000778	CcSEcCtD
Darifenacin—Headache—Triamcinolone—ulcerative colitis	0.000281	0.000776	CcSEcCtD
Darifenacin—Headache—Methylprednisolone—ulcerative colitis	0.00028	0.000774	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—ulcerative colitis	0.00028	0.000774	CcSEcCtD
Darifenacin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000278	0.000769	CcSEcCtD
Darifenacin—Diarrhoea—Betamethasone—ulcerative colitis	0.000278	0.000769	CcSEcCtD
Darifenacin—Dizziness—Betamethasone—ulcerative colitis	0.000269	0.000743	CcSEcCtD
Darifenacin—Dizziness—Dexamethasone—ulcerative colitis	0.000269	0.000743	CcSEcCtD
Darifenacin—Nausea—Triamcinolone—ulcerative colitis	0.000266	0.000736	CcSEcCtD
Darifenacin—Nausea—Methylprednisolone—ulcerative colitis	0.000266	0.000734	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—ulcerative colitis	0.000261	0.000721	CcSEcCtD
Darifenacin—Vomiting—Betamethasone—ulcerative colitis	0.000258	0.000714	CcSEcCtD
Darifenacin—Vomiting—Dexamethasone—ulcerative colitis	0.000258	0.000714	CcSEcCtD
Darifenacin—Rash—Dexamethasone—ulcerative colitis	0.000256	0.000708	CcSEcCtD
Darifenacin—Rash—Betamethasone—ulcerative colitis	0.000256	0.000708	CcSEcCtD
Darifenacin—Dermatitis—Dexamethasone—ulcerative colitis	0.000256	0.000708	CcSEcCtD
Darifenacin—Dermatitis—Betamethasone—ulcerative colitis	0.000256	0.000708	CcSEcCtD
Darifenacin—Headache—Dexamethasone—ulcerative colitis	0.000255	0.000704	CcSEcCtD
Darifenacin—Headache—Betamethasone—ulcerative colitis	0.000255	0.000704	CcSEcCtD
Darifenacin—Asthenia—Prednisone—ulcerative colitis	0.000254	0.000702	CcSEcCtD
Darifenacin—Pruritus—Prednisone—ulcerative colitis	0.00025	0.000692	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—ulcerative colitis	0.000242	0.00067	CcSEcCtD
Darifenacin—Nausea—Dexamethasone—ulcerative colitis	0.000241	0.000667	CcSEcCtD
Darifenacin—Nausea—Betamethasone—ulcerative colitis	0.000241	0.000667	CcSEcCtD
Darifenacin—Dizziness—Prednisone—ulcerative colitis	0.000234	0.000647	CcSEcCtD
Darifenacin—Vomiting—Prednisone—ulcerative colitis	0.000225	0.000622	CcSEcCtD
Darifenacin—Rash—Prednisone—ulcerative colitis	0.000223	0.000617	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—ulcerative colitis	0.000223	0.000616	CcSEcCtD
Darifenacin—Headache—Prednisone—ulcerative colitis	0.000222	0.000613	CcSEcCtD
Darifenacin—Nausea—Prednisone—ulcerative colitis	0.00021	0.000581	CcSEcCtD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.04e-05	0.00127	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GNA12—ulcerative colitis	6.04e-05	0.00127	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.02e-05	0.00126	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—GHRL—ulcerative colitis	5.92e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL20—ulcerative colitis	5.91e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCR1—ulcerative colitis	5.89e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL20—ulcerative colitis	5.89e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL20—ulcerative colitis	5.83e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	5.8e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.8e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCR2—ulcerative colitis	5.78e-05	0.00121	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CALM3—ulcerative colitis	5.73e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCR2—ulcerative colitis	5.72e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—GHRL—ulcerative colitis	5.67e-05	0.00119	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCR1—ulcerative colitis	5.64e-05	0.00119	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GNA12—ulcerative colitis	5.55e-05	0.00117	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GNA12—ulcerative colitis	5.54e-05	0.00116	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CALM3—ulcerative colitis	5.49e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GNA12—ulcerative colitis	5.48e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR6—ulcerative colitis	5.45e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR6—ulcerative colitis	5.43e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—ADRB2—ulcerative colitis	5.39e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR6—ulcerative colitis	5.38e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCR2—ulcerative colitis	5.26e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCR2—ulcerative colitis	5.25e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCR2—ulcerative colitis	5.2e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL20—ulcerative colitis	5.17e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—ADRB2—ulcerative colitis	5.16e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL8—ulcerative colitis	5.07e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL20—ulcerative colitis	4.95e-05	0.00104	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR6—ulcerative colitis	4.95e-05	0.00104	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR6—ulcerative colitis	4.93e-05	0.00104	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—ADRB2—ulcerative colitis	4.9e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	4.89e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR6—ulcerative colitis	4.89e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GNA12—ulcerative colitis	4.86e-05	0.00102	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SEL1L—ulcerative colitis	4.83e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SEL1L—ulcerative colitis	4.81e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	4.8e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PTGER4—ulcerative colitis	4.78e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SEL1L—ulcerative colitis	4.76e-05	0.001	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PTGER4—ulcerative colitis	4.74e-05	0.000995	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—ADRB2—ulcerative colitis	4.69e-05	0.000986	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GNA12—ulcerative colitis	4.66e-05	0.000979	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCR2—ulcerative colitis	4.61e-05	0.000969	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL8—ulcerative colitis	4.61e-05	0.000969	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—ADCY5—ulcerative colitis	4.58e-05	0.000962	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCR2—ulcerative colitis	4.42e-05	0.000928	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL8—ulcerative colitis	4.41e-05	0.000928	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.4e-05	0.000924	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GHRL—ulcerative colitis	4.39e-05	0.000923	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—ADCY5—ulcerative colitis	4.38e-05	0.000921	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GHRL—ulcerative colitis	4.38e-05	0.00092	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PTGER4—ulcerative colitis	4.36e-05	0.000916	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PTGER4—ulcerative colitis	4.34e-05	0.000913	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GHRL—ulcerative colitis	4.34e-05	0.000911	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR6—ulcerative colitis	4.34e-05	0.000911	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CHP1—ulcerative colitis	4.33e-05	0.00091	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PTGER4—ulcerative colitis	4.3e-05	0.000904	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—ADCY5—ulcerative colitis	4.16e-05	0.000874	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR6—ulcerative colitis	4.15e-05	0.000873	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAML2—ulcerative colitis	4.11e-05	0.000864	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.08e-05	0.000858	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.07e-05	0.000855	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.03e-05	0.000847	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GHRL—ulcerative colitis	3.99e-05	0.000838	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—ADCY5—ulcerative colitis	3.98e-05	0.000837	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GHRL—ulcerative colitis	3.98e-05	0.000836	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCR1—ulcerative colitis	3.97e-05	0.000835	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCR1—ulcerative colitis	3.96e-05	0.000832	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.95e-05	0.00083	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GHRL—ulcerative colitis	3.94e-05	0.000828	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAML2—ulcerative colitis	3.94e-05	0.000827	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCR1—ulcerative colitis	3.92e-05	0.000824	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CALM3—ulcerative colitis	3.86e-05	0.000812	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CALM3—ulcerative colitis	3.85e-05	0.000809	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTGER4—ulcerative colitis	3.82e-05	0.000802	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	3.81e-05	0.000801	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—DLD—ulcerative colitis	3.74e-05	0.000785	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTGER4—ulcerative colitis	3.66e-05	0.000768	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	3.64e-05	0.000764	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—ADRB2—ulcerative colitis	3.62e-05	0.000762	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	3.59e-05	0.000754	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	3.57e-05	0.00075	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GHRL—ulcerative colitis	3.5e-05	0.000734	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	3.49e-05	0.000733	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL20—ulcerative colitis	3.48e-05	0.000731	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	3.44e-05	0.000724	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CALM3—ulcerative colitis	3.38e-05	0.000711	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GHRL—ulcerative colitis	3.35e-05	0.000703	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RIPK2—ulcerative colitis	3.33e-05	0.000701	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	3.3e-05	0.000694	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADRB2—ulcerative colitis	3.29e-05	0.000692	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	3.28e-05	0.000689	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GNA12—ulcerative colitis	3.27e-05	0.000687	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	3.27e-05	0.000687	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	3.26e-05	0.000685	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CALM3—ulcerative colitis	3.24e-05	0.000681	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	3.24e-05	0.00068	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RIPK2—ulcerative colitis	3.19e-05	0.000671	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	3.11e-05	0.000653	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	3.11e-05	0.000653	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCR2—ulcerative colitis	3.1e-05	0.000651	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL8—ulcerative colitis	3.1e-05	0.000651	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.1e-05	0.000651	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	3.09e-05	0.000649	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.09e-05	0.000649	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—ADCY5—ulcerative colitis	3.08e-05	0.000647	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	3.07e-05	0.000645	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	3.07e-05	0.000645	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	3.05e-05	0.00064	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS1—ulcerative colitis	3.02e-05	0.000635	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	2.92e-05	0.000614	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR6—ulcerative colitis	2.91e-05	0.000612	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADRB2—ulcerative colitis	2.89e-05	0.000608	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	2.89e-05	0.000607	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—JAK2—ulcerative colitis	2.85e-05	0.0006	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CHP1—ulcerative colitis	2.83e-05	0.000595	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	2.8e-05	0.000589	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADCY5—ulcerative colitis	2.79e-05	0.000587	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	2.77e-05	0.000582	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADRB2—ulcerative colitis	2.77e-05	0.000582	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	2.77e-05	0.000581	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAML2—ulcerative colitis	2.76e-05	0.000581	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	2.74e-05	0.000575	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—JAK2—ulcerative colitis	2.73e-05	0.000574	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CALM3—ulcerative colitis	2.72e-05	0.000572	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL8—ulcerative colitis	2.6e-05	0.000547	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—JAK2—ulcerative colitis	2.59e-05	0.000545	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	2.57e-05	0.000541	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTGER4—ulcerative colitis	2.57e-05	0.000539	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	2.54e-05	0.000534	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	2.49e-05	0.000524	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—ulcerative colitis	2.49e-05	0.000523	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—JAK2—ulcerative colitis	2.48e-05	0.000522	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADCY5—ulcerative colitis	2.46e-05	0.000516	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DLD—ulcerative colitis	2.44e-05	0.000514	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—ulcerative colitis	2.38e-05	0.000501	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL8—ulcerative colitis	2.37e-05	0.000497	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	2.36e-05	0.000495	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADCY5—ulcerative colitis	2.35e-05	0.000494	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GHRL—ulcerative colitis	2.35e-05	0.000494	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	2.33e-05	0.000489	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	2.28e-05	0.00048	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CALM3—ulcerative colitis	2.28e-05	0.000478	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL8—ulcerative colitis	2.27e-05	0.000476	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—ulcerative colitis	2.26e-05	0.000475	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	2.25e-05	0.000473	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	2.25e-05	0.000472	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RIPK2—ulcerative colitis	2.24e-05	0.000471	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	2.22e-05	0.000466	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—ulcerative colitis	2.16e-05	0.000455	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCB1—ulcerative colitis	2.12e-05	0.000445	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ADCY5—ulcerative colitis	1.97e-05	0.000415	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	1.95e-05	0.00041	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRB2—ulcerative colitis	1.94e-05	0.000409	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	1.93e-05	0.000405	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	1.92e-05	0.000404	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—JAK2—ulcerative colitis	1.92e-05	0.000403	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	1.9e-05	0.000399	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.81e-05	0.00038	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.76e-05	0.000369	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL8—ulcerative colitis	1.75e-05	0.000368	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	1.75e-05	0.000367	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—JAK2—ulcerative colitis	1.74e-05	0.000366	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.73e-05	0.000364	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	1.72e-05	0.000362	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	1.68e-05	0.000353	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—ulcerative colitis	1.67e-05	0.000352	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	1.66e-05	0.000348	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	1.66e-05	0.000348	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADCY5—ulcerative colitis	1.65e-05	0.000347	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	1.63e-05	0.000343	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.63e-05	0.000342	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	1.59e-05	0.000335	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—ulcerative colitis	1.59e-05	0.000334	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	1.57e-05	0.000331	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JAK2—ulcerative colitis	1.53e-05	0.000322	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	1.52e-05	0.00032	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—ulcerative colitis	1.52e-05	0.000319	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	1.5e-05	0.000316	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RELA—ulcerative colitis	1.48e-05	0.000312	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—ulcerative colitis	1.47e-05	0.000309	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JAK2—ulcerative colitis	1.47e-05	0.000308	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RELA—ulcerative colitis	1.42e-05	0.000298	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—ulcerative colitis	1.4e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	1.34e-05	0.000281	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—ulcerative colitis	1.34e-05	0.000281	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—ulcerative colitis	1.33e-05	0.000279	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—ulcerative colitis	1.32e-05	0.000278	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—ulcerative colitis	1.28e-05	0.000269	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	1.27e-05	0.000267	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.27e-05	0.000266	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—ulcerative colitis	1.26e-05	0.000266	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NFKB1—ulcerative colitis	1.25e-05	0.000263	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	1.21e-05	0.000254	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	1.2e-05	0.000252	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.18e-05	0.000248	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.18e-05	0.000248	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—ulcerative colitis	1.16e-05	0.000243	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—ulcerative colitis	1.12e-05	0.000236	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	1.08e-05	0.000226	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.06e-05	0.000224	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—ulcerative colitis	1.04e-05	0.000219	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	1.03e-05	0.000217	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	1.03e-05	0.000216	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	1.02e-05	0.000214	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RELA—ulcerative colitis	1e-05	0.00021	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	9.97e-06	0.00021	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RELA—ulcerative colitis	9.97e-06	0.000209	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RELA—ulcerative colitis	9.87e-06	0.000207	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	9.42e-06	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	9.39e-06	0.000197	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	9.3e-06	0.000195	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—ulcerative colitis	9e-06	0.000189	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—ulcerative colitis	8.98e-06	0.000189	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	8.96e-06	0.000188	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	8.93e-06	0.000188	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—ulcerative colitis	8.89e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	8.84e-06	0.000186	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—ulcerative colitis	8.8e-06	0.000185	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—ulcerative colitis	8.57e-06	0.00018	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	8.52e-06	0.000179	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	8.49e-06	0.000179	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	8.43e-06	0.000177	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	8.41e-06	0.000177	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	8.4e-06	0.000177	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	8.32e-06	0.000175	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	8.27e-06	0.000174	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—ulcerative colitis	8.21e-06	0.000173	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—ulcerative colitis	7.91e-06	0.000166	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—ulcerative colitis	7.85e-06	0.000165	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.72e-06	0.000162	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	7.58e-06	0.000159	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	7.55e-06	0.000159	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—ulcerative colitis	7.52e-06	0.000158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	7.48e-06	0.000157	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	7.02e-06	0.000148	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	7e-06	0.000147	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	6.93e-06	0.000146	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—ulcerative colitis	6.92e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—ulcerative colitis	5.78e-06	0.000122	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—ulcerative colitis	5.76e-06	0.000121	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.75e-06	0.000121	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—ulcerative colitis	5.71e-06	0.00012	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—ulcerative colitis	5.29e-06	0.000111	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—ulcerative colitis	5.28e-06	0.000111	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—ulcerative colitis	5.22e-06	0.00011	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—ulcerative colitis	5.17e-06	0.000109	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.53e-06	9.51e-05	CbGpPWpGaD
